Alzheimer's Disease: Biomarkers And Future Targets For Drug Intervention release_x2656sjerffxjfnvjkrgspgtz4

by Reni P Paul, Arul Balasubramanian, Kothai Ramalingam

Published in International Journal of Research in Pharmaceutical Sciences by GP Innovations Pvt. Ltd..

2020   Volume 11, p3850-3856

Abstract

Alzheimer's disease is a progressive disorder and the most common types of dementia that develops in the elderly, characterised by gradual memory loss and cognitive skills of an individual. The neurodegenerative disease is characterised by intracellular settling of hyperphosphorylated tau protein like neurofibrillary tangles (NFT) in the neuronal cytoplasm and extracellular settling of beta-amyloid peptide(Aβ). These changes lead to cognitive decline due to the loss of synapses and neurons involved in learning, memory and cognitive function. Amyloid precursor protein, presenilin 1, presenilin 2 and TREM2 are some of the genes involved in the development of the disease. The current treatment for AD is the cholinesterase inhibitors such as donepezil, galantamine, rivastigmine, and N-methyl D- aspartate antagonist memantine. Other recommended adjuvant therapy was vitamin D, omega-3 fatty acid, Mediterranean diet, and aerobic exercise. Diagnosis is based upon clinical presentation and imaging biomarkers. This review summarises AD biomarkers such as cerebrospinal fluid biomarkers, circulatory biomarkers, inflammatory markers and oxidative biomarkers which are under study and the future targets of drug intervention. The amyloid-beta peptide, tau protein, and β-secretase may be the possible sites of drug action in the future.
In application/xml+jats format

Archived Files and Locations

application/pdf  219.6 kB
file_es4r7gv755hulnfmnp74qlpgmi
pharmascope.org (publisher)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2020-07-21
Journal Metadata
Open Access Publication
Not in DOAJ
In ISSN ROAD
Not in Keepers Registry
ISSN-L:  0975-7538
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 528baf2a-48b2-4376-98fc-257bea5e7181
API URL: JSON